持续性週边神经阻断导管市场：按类型、导引技术、最终用户和应用划分－2026-2032年全球预测

2025 年，持续性週边神经阻断导管市场价值为 4.2618 亿美元，预计到 2026 年将成长至 4.5017 亿美元，复合年增长率为 5.88%，到 2032 年将达到 6.3601 亿美元。

主要市场统计数据
基准年 2025	4.2618亿美元
预计年份：2026年	4.5017亿美元
预测年份 2032	6.3601亿美元
复合年增长率 (%)	5.88%

权威概述了影响将连续性週边神经阻断导管引入现代医疗路径的临床、操作和采购因素的演变。

持续性週边神经阻断导管已成为术前和术后疼痛管理的核心，它能提供标靶镇痛，减少全身性阿片类药物依赖，并促进患者康復。近年来，临床医生和采购团队都对导管的设计、与引导技术的兼容性以及与多方面镇痛通讯协定的整合便捷性等设备特性进行了深入研究。这些因素促使医疗机构在评估和实施持续性神经阻断方案时发生了转变，关注点从单一操作的效用转向更广泛的围手术全期护理路径，强调缩短住院时间和改善功能恢復。

对临床重点、影像引导技术的进步以及医疗保健服务的变化如何汇聚，从而重新定义设备开发和部署的动态进行全面评估。

持续性週边神经阻断导管的市场格局正在经历变革性变化，其驱动因素包括临床需求、技术融合以及医疗服务模式的转变。临床上，减少阿片类药物使用和加速復健通讯协定的策略正显着增加，这使得可靠的局部麻醉技术变得尤为重要。这种临床需求促使人们需要能够提供可预测镇痛效果，并在适当情况下支持早期物理治疗和当日出院的器械。

对 2025 年价格调整对营运和采购的影响进行分析概述，以及供应链调整如何重塑商业策略。

2025年关税政策的实施为医疗设备产业的采购、供应链管理和商业策略带来了新的复杂性。关税调整将影响製造、分销和采购管道的成本结构，要求相关人员重新评估筹资策略和利润率预期。对于依赖跨境供应链的製造商而言，这些变化促使他们审查供应商合约、在地采购，并探索建立库存缓衝，以降低进口关税波动带来的风险并增强抵御风险的能力。

综合細項分析，解释导管类型、影像和引导方法、临床环境和手术应用如何共同影响采购和实施决策。

细分市场分析揭示了设备选择和临床部署如何因产品类型、引导技术、终端用户环境和应用而异，每种情况都形成了其独特的部署路径。在按导管类型区分设备时，重点在于预期手术以及临床医生在非刺激性导管（便于插入）和刺激性导管（可在放置过程中提供神经定位反馈）之间的偏好。这种差异会影响训练要求和手术通讯协定，因为在临床实务中采用电刺激确认神经接近性的方法时，刺激性导管可能会更受欢迎。

本文阐述了美洲、欧洲、中东和非洲以及亚太地区的基础设施、报销制度和临床实践如何影响设备部署和商业化策略的细微区域差异。

区域动态，受医疗基础设施、报销系统和临床实践模式差异的影响，对医疗设备的选择、临床培训模式和分销策略产生显着影响。在美洲，临床上对加速復健、整形外科病例和产科服务的重视，推动了对支持早期復健和高安全性医疗设备的需求。在都市区三级医疗机构中，先进影像技术和跨学科协作受到重视，而门诊机构则优先考虑能够最大限度缩短手术时间并实现当日出院的医疗设备。

对产品创新、临床医生教育和服务模式如何整合以建立竞争优势并影响局部麻醉领域的采购选择进行策略性评估。

持续性週边神经阻断导管市场的竞争格局主要集中在产品创新、临床支援服务以及在真实临床环境中展现稳定性能的能力。领先的製造商透过导管材料和固定係统来降低导管脱落和感染的风险，并透过简化无菌操作和超音波整合的配件包来脱颖而出。同样重要的是培训项目、模拟工具和临床伙伴关係，这些都能透过提高临床医师的信心和操作一致性来加速产品的普及应用。

为製造商和医疗保健领导者提供实用建议，以使其产品开发、临床医生培训和供应策略与临床和营运重点保持一致。

产业领导者可以透过调整研发重点与终端用户工作流程，并加强临床支援体系，采取果断行动，确保抓住临床和商业性机会。他们可以透过优先提升导管功能，改善超音波影像视觉化、确保导管牢固固定并控制感染，来解决临床医生最常提及的实际挑战。同时，投资扩充性的培训项目和模拟工具，可以降低技能差异，加速技术应用，尤其是在医院和门诊中心等对操作人员一致性要求极高的场所。

高度透明的调查方法解释瞭如何将与临床医生的初步访谈、临床指南的整合以及产品比较分析相结合，从而得出可操作的见解。

本研究整合了同侪审查的临床文献、操作指南以及对麻醉医师、手术全期护理师和采购负责人的初步定性访谈，旨在全面了解推动医疗器材应用的因素及其障碍。调查方法强调临床实务洞察、产品功能评估和分销管道分析之间的交叉检验，以确保结论既反映实证医学，又符合日常营运的实际情况。

简洁而前瞻性的结论，整合了临床重点、操作实际情况和协作策略，以支持有效引入持续性週边神经阻断导管。

总之，持续性週边神经阻断导管在现代疼痛管理策略中发挥着至关重要的作用，其应用受到多种因素的共同影响：临床需求、影像技术的进步以及不断发展的医疗服务模式。该装置的特性——与超音波的整合、牢固的固定以及可在门诊进行管理——始终与门诊手术中心、医院和专科诊所等各相关人员的优先事项相契合。同时，持续投入临床医生培训和实证医学研究对于维持其应用和提高操作规范性仍然至关重要。

目录

第一章：序言

第二章：调查方法

• 调查设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查的前提
• 研究限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 市场进入策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会映射
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：持续性週边神经阻断导管市场：依类型划分

• 非刺激性导管
• 刺激导管

第九章：依诱导技术分類的连续性週边神经阻断导管市场

• 盲法
• 神经刺激设备引导法
• 超音波引导法

第十章：持续性週边神经阻断导管市场：依最终用户划分

• 门诊手术中心
• 医院
• 专科诊所

第十一章：持续性週边神经阻断导管市场：依应用领域划分

• 产科镇痛
  • 剖腹产
  • 分娩疼痛管理
• 整形外科手术
  • 全髋关节置换术
  • 人工膝关节关节重建手术
  • 肩关节手术
• 术后疼痛管理

第十二章：连续性週边神经阻断导管市场：依地区划分

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章：持续性週边神经阻断导管市场：依组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章：持续性週边神经阻断导管市场：依国家划分

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章：美国持续性週边神经阻断导管市场

第十六章：中国週边神经阻断导管市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Avanos Medical, Inc.
• B. Braun Melsungen AG
• Dyna Medical Corporation
• Epimed International Inc.
• ICU Medical, Inc.
• Lepu Medical Technology（Beijing）Co., Ltd.
• Medline Industries, LP
• Medtronic plc
• Merit Medical Systems, Inc.
• Nipro Corporation
• Owens & Minor, Inc.
• PAJUNK GmbH Medizintechnologie
• Poly Medicure Ltd.
• Shunmei
• Teleflex Incorporated
• Vygon SA

The Continuous Peripheral Nerve Block Catheter Market was valued at USD 426.18 million in 2025 and is projected to grow to USD 450.17 million in 2026, with a CAGR of 5.88%, reaching USD 636.01 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 426.18 million
Estimated Year [2026]	USD 450.17 million
Forecast Year [2032]	USD 636.01 million
CAGR (%)	5.88%

An authoritative introduction describing the evolving clinical, operational, and procurement drivers shaping continuous peripheral nerve block catheter adoption in modern care pathways

Continuous peripheral nerve block catheters have become a focal point in perioperative pain management, offering targeted analgesia that reduces systemic opioid reliance and enhances patient recovery. Over recent years, clinicians and procurement teams alike have scrutinized device characteristics such as catheter design, guidance technology compatibility, and ease of integration into multimodal analgesia protocols. These factors have driven an evolution in how healthcare organizations evaluate and adopt continuous nerve block solutions, with attention shifting from single-procedure utility toward broader perioperative pathways that emphasize reduced length of stay and improved functional recovery.

In parallel, clinical practice has increasingly favored technologies that align with enhanced recovery after surgery principles and ambulatory surgical care models. This trend has raised new expectations for device performance, including consistent block efficacy, secure fixation methods that permit early mobilization, and user interfaces that minimize procedure time. As a result, manufacturers and clinical leaders are forging closer collaborations to refine training, standardize protocols, and validate real-world outcomes, creating an environment where technological innovation and clinical evidence jointly influence purchasing and adoption decisions.

Consequently, stakeholders require clear, evidence-driven intelligence that synthesizes device design considerations, guidance technology implications, and end-user perspectives to inform procurement, clinician education, and value-based purchasing strategies. This report seeks to deliver that actionable intelligence by examining market dynamics, clinical adoption patterns, and practical recommendations for integrating continuous peripheral nerve block catheters into contemporary care pathways.

A comprehensive assessment of how clinical priorities, imaging guidance advances, and care delivery changes are converging to redefine device development and adoption dynamics

The landscape for continuous peripheral nerve block catheters is undergoing transformative shifts driven by clinical priorities, technology convergence, and changes in care delivery. Clinically, there is a pronounced move toward opioid-sparing strategies and enhanced recovery protocols, which elevates the importance of reliable regional anesthesia techniques. This clinical imperative has amplified demand for devices that deliver predictable analgesia while enabling early physiotherapy and same-day discharge where appropriate.

Technologically, the convergence of imaging guidance and catheter design is reshaping procedural workflows. Ultrasound guidance has emerged as a preferred modality in many settings because it improves visualization of nerve structures and local anesthetic spread, thereby enhancing block accuracy and safety. Simultaneously, manufacturers are optimizing catheter materials and fixation systems to reduce dislodgement and infection risk, which addresses key practical barriers encountered in ambulatory and inpatient environments. These technological advancements are complemented by improved training tools and simulation-based education that accelerate clinician competency and adoption.

Operational shifts in healthcare delivery also influence the trajectory of adoption. The growth of ambulatory surgical centers and shared-care models places a premium on devices that support streamlined procedures and consistent outcomes across disparate settings. In addition, evolving reimbursement frameworks and quality metrics emphasize patient-reported outcomes and reductions in opioid-related adverse events, creating incentives for hospitals and clinics to prioritize regional anesthesia solutions. Taken together, these clinical, technological, and operational forces are redirecting development priorities and commercial strategies across the value chain.

An analytical overview of the operational and procurement implications stemming from 2025 tariff changes and how supply chain adjustments are reshaping commercial strategies

The introduction of tariff policies in 2025 has introduced a new layer of complexity for procurement, supply chain management, and commercial strategy within the medical device sector. Tariff adjustments influence cost structures across manufacturing, distribution, and procurement channels, requiring stakeholders to reassess sourcing strategies and margin expectations. For manufacturers that rely on cross-border supply chains, these changes have triggered a review of supplier contracts, component localization, and inventory buffers to mitigate exposure to variable import duties and broaden resilience.

Hospitals and ambulatory centers respond to altered cost dynamics by tightening procurement specifications, extending tender cycles, and prioritizing devices that demonstrate not only clinical value but also predictable total cost of ownership. In some cases, purchasers explore alternative supplier relationships or consolidated purchasing agreements to offset additional tariff-induced costs. Meanwhile, smaller specialty clinics may face greater sensitivity to price changes, prompting clinicians to evaluate procedural workflows and device utilization to preserve access to regional anesthesia techniques without eroding clinical quality.

In response, manufacturers and distributors are exploring adaptive strategies such as nearshoring select production, redesigning packaging to reduce tariff exposure, and offering bundled service models that emphasize training, warranty, and consumable management. These approaches aim to preserve competitiveness while maintaining the clinical performance and support services that clinicians expect. The net effect of tariff changes is therefore not only financial but operational, compelling stakeholders to pursue pragmatic adjustments that sustain clinical access and long-term supplier partnerships.

An integrated segmentation analysis explaining how catheter type, imaging and guidance methods, clinical setting, and procedural application jointly determine procurement and adoption decisions

Insight into segmentation reveals how device selection and clinical deployment vary across product type, guidance technology, end-user setting, and application, each shaping distinct adoption pathways. When devices are differentiated by catheter type, considerations center on the intended procedural use and clinician preference for either nonstimulating catheters that simplify insertion or stimulating catheters that provide nerve localization feedback during placement. This distinction influences training requirements and procedural protocols because stimulating catheters may be favored in settings where electrical confirmation of nerve proximity is integrated into clinical practice.

Guidance technology further stratifies clinical workflows and device compatibility. Blind techniques continue to persist in certain resource-constrained environments, but nerve stimulator-guided approaches offer incremental confidence through motor response confirmation. Ultrasound guidance, by contrast, has redefined standards of practice in many centers by providing direct visualization of anatomy, which improves block accuracy and reduces reliance on secondary localization methods. As a result, device features that facilitate ultrasound visualization, such as echogenic catheter design and compatible insertion kits, resonate strongly with teams prioritizing image-guided regional anesthesia.

End-user environments also affect procurement and utilization patterns. Ambulatory surgical centers prioritize rapid turnover, minimal opioid-related complications, and devices that streamline same-day discharge. Hospitals often balance a broader case mix and invest in clinician training and multidisciplinary pathways that support continuous catheter programs across orthopedic and obstetric services. Specialty clinics concentrate on procedure-specific workflows and may adopt devices that align with focused clinical protocols and patient throughput demands.

Applications provide a final lens through which clinicians assess catheter solutions. Obstetric analgesia requires devices and protocols suited for both cesarean delivery and labor pain management, with emphasis on maternal mobility and neonatal safety. Orthopedic surgery presents diverse needs across hip, knee, and shoulder procedures, with pain control strategies that facilitate early mobilization and rehabilitation. Postoperative pain management beyond the operating theater demands secure catheter fixation, infection prevention measures, and clear outpatient protocols to support home-based analgesia when indicated. Taken together, these segmentation perspectives reveal why device portfolios and go-to-market approaches must align tightly with clinical workflows and setting-specific priorities.

A nuanced regional perspective illustrating how infrastructure, reimbursement, and practice variation across the Americas, EMEA, and Asia-Pacific influence device adoption and commercialization strategies

Regional dynamics exert a powerful influence on device selection, clinical training models, and distribution strategies, shaped by differences in healthcare infrastructure, reimbursement practices, and clinical practice patterns. In the Americas, clinical emphasis on enhanced recovery, orthopedic volume, and obstetric services drives interest in devices that support accelerated rehabilitation and strong safety profiles. Urban tertiary centers emphasize advanced imaging integration and multidisciplinary pathways, while ambulatory sites prioritize devices that minimize procedure time and support same-day discharge.

Across Europe, the Middle East, and Africa, heterogeneity in healthcare systems creates diverse adoption environments. High-resource hospitals in Western Europe typically adopt ultrasound-guided regional anesthesia widely, investing in simulation-based clinician training and standardized protocols. Meanwhile, in some parts of the Middle East and Africa, variability in access to imaging equipment and trained personnel leads to continued use of alternative guidance strategies and greater sensitivity to device cost and durability. Distribution networks and regulatory pathways also differ across this broad region, influencing how manufacturers structure market entry and support services.

In the Asia-Pacific region, rapid growth of surgical volumes and expanding ambulatory care capacity drive demand for solutions that can scale across high-throughput settings. Training programs and partnerships with academic centers accelerate adoption of image-guided techniques in many markets, while localized manufacturing and supply arrangements often influence procurement decisions. Across these regions, stakeholders respond to both global clinical trends and region-specific constraints, prompting manufacturers to tailor commercial models, educational outreach, and service offerings to local needs while maintaining consistent device performance standards.

A strategic evaluation of how product innovation, clinician education, and service models converge to define competitive advantage and influence procurement choices in regional anesthesia

Competitive dynamics in the continuous peripheral nerve block catheter space center on product innovation, clinical support services, and the ability to demonstrate consistent performance in real-world settings. Leading manufacturers differentiate through catheter materials and fixation systems designed to reduce dislodgement and infection risk, as well as through accessory kits that simplify sterile technique and ultrasound integration. Equally important are training programs, simulation tools, and clinical partnerships that accelerate adoption by improving clinician confidence and procedural consistency.

Distribution and service models also underpin competitive positioning. Firms that offer bundled solutions combining devices, clinician education, and post-market surveillance gain traction with hospital systems seeking predictable outcomes and reduced operational burden. Strategic collaborations with imaging equipment providers, anesthesiology societies, and academic centers amplify visibility and support guideline-aligned practice adoption. Vendors that maintain responsive supply chains and localized technical support tend to perform better in markets where hospitals prioritize service continuity and rapid device replenishment.

Finally, companies that invest in evidence generation through registries, observational studies, and pragmatic clinical collaborations help to validate real-world effectiveness and inform best practices. This clinical evidence, when paired with robust training and service ecosystems, reinforces trust among clinician champions and purchasing committees, creating a durable competitive advantage that extends beyond product specifications alone.

Actionable recommendations for manufacturers and healthcare leaders to align product development, clinician training, and supply strategies with real-world clinical and operational priorities

Industry leaders can act decisively to capture clinical and commercial opportunities by aligning R&D priorities with end-user workflows and by strengthening clinical support capabilities. Prioritizing catheter features that enhance ultrasound visualization, secure fixation, and infection control will address the practical pain points most commonly cited by clinicians. In parallel, investing in scalable training programs and simulation tools will reduce variability in technique and accelerate adoption, particularly in hospitals and ambulatory centers seeking operator consistency.

Operationally, manufacturers should consider supply chain strategies that reduce exposure to tariff variability and improve responsiveness to regional demand fluctuations. Options include selectively nearshoring high-volume production, developing modular packaging to mitigate tariff thresholds, and formalizing service-level agreements that assure timely replenishment. Commercial teams should emphasize bundled offerings that link device procurement with clinician education, warranty support, and data collection options to quantify procedural outcomes and patient experience.

From a market engagement perspective, leaders should cultivate partnerships with orthopedic and obstetric clinical champions to generate real-world evidence and disseminate best-practice protocols. Tailored value propositions for ambulatory surgical centers, hospitals, and specialty clinics will help address setting-specific priorities such as throughput, rehabilitation timelines, and outpatient catheter management. By integrating clinical, operational, and commercial initiatives, industry players can create compelling, differentiated offerings that support sustainable adoption across diverse care settings.

A transparent research methodology describing how primary clinician interviews, clinical guidance synthesis, and comparative product analysis were integrated to produce actionable insights

This research synthesizes peer-reviewed clinical literature, procedural guidelines, and primary qualitative interviews with anesthesiologists, perioperative nurses, and procurement specialists to develop a comprehensive understanding of device adoption drivers and barriers. The methodology emphasizes triangulation between clinical practice insights, product feature evaluations, and distribution channel analysis to ensure that conclusions reflect both evidence-based medicine and day-to-day operational realities.

Primary data collection included structured interviews and thematic analysis designed to capture clinician preferences around catheter type, guidance technology, and outpatient management. Secondary sources included recent procedural guidelines and device safety communications that inform best practices for infection prevention and catheter fixation. Throughout the process, attention focused on capturing heterogeneity across ambulatory centers, hospitals, and specialty clinics to ensure findings remain applicable across the primary end-user environments.

Analytical methods combined qualitative synthesis with comparative feature mapping across device portfolios and regional market dynamics. Supply chain and policy impacts were assessed through scenario analysis that considered common procurement responses and manufacturer mitigations. The resulting approach prioritizes actionable insight over abstract modeling, delivering recommendations that operational and clinical leaders can implement to optimize adoption and patient outcomes.

A concise and forward-looking conclusion that synthesizes clinical priorities, operational realities, and collaborative strategies underpinning effective adoption of continuous peripheral nerve block catheters

In conclusion, continuous peripheral nerve block catheters occupy a pivotal role in contemporary pain management strategies, with adoption shaped by a confluence of clinical imperatives, imaging technology advances, and evolving care delivery models. Device characteristics that support ultrasound integration, secure fixation, and outpatient management consistently align with stakeholder priorities across ambulatory surgical centers, hospitals, and specialty clinics. Meanwhile, ongoing investments in clinician training and evidence generation remain central to sustaining adoption and improving procedural consistency.

Operational forces, including supply chain resilience and policy shifts, require coordinated responses from manufacturers and procurement teams to preserve access and maintain value-based care objectives. Manufacturers that couple product innovation with robust training, service support, and adaptive supply strategies will be best positioned to meet the complex needs of diverse healthcare settings. Ultimately, sustained collaboration between clinical leaders, industry partners, and institutional purchasers will determine how effectively continuous peripheral nerve block catheters enhance patient recovery while advancing quality and efficiency objectives.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Continuous Peripheral Nerve Block Catheter Market, by Type

• 8.1. Non Stimulating Catheter
• 8.2. Stimulating Catheter

9. Continuous Peripheral Nerve Block Catheter Market, by Guidance Technology

• 9.1. Blind Technique
• 9.2. Nerve Stimulator Guided
• 9.3. Ultrasound Guided

10. Continuous Peripheral Nerve Block Catheter Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Hospitals
• 10.3. Specialty Clinics

11. Continuous Peripheral Nerve Block Catheter Market, by Application

• 11.1. Obstetric Analgesia
  • 11.1.1. C Section
  • 11.1.2. Labor Pain Management
• 11.2. Orthopedic Surgery
  • 11.2.1. Hip Replacement
  • 11.2.2. Knee Replacement
  • 11.2.3. Shoulder Surgery
• 11.3. Postoperative Pain Management

12. Continuous Peripheral Nerve Block Catheter Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Continuous Peripheral Nerve Block Catheter Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Continuous Peripheral Nerve Block Catheter Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Continuous Peripheral Nerve Block Catheter Market

16. China Continuous Peripheral Nerve Block Catheter Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Avanos Medical, Inc.
• 17.6. B. Braun Melsungen AG
• 17.7. Dyna Medical Corporation
• 17.8. Epimed International Inc.
• 17.9. ICU Medical, Inc.
• 17.10. Lepu Medical Technology (Beijing) Co., Ltd.
• 17.11. Medline Industries, LP
• 17.12. Medtronic plc
• 17.13. Merit Medical Systems, Inc.
• 17.14. Nipro Corporation
• 17.15. Owens & Minor, Inc.
• 17.16. PAJUNK GmbH Medizintechnologie
• 17.17. Poly Medicure Ltd.
• 17.18. Shunmei
• 17.19. Teleflex Incorporated
• 17.20. Vygon SA

LIST OF FIGURES

• FIGURE 1. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 57. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 58. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 59. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 60. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 61. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 62. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 63. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 64. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 65. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 66. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 67. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 68. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 69. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 70. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 71. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 72. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 73. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 74. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 75. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 76. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 77. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 85. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 86. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 87. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 88. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 89. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 90. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 91. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 92. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 93. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 94. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 95. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 96. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 97. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 98. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 99. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 101. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 102. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 103. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 104. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 105. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 106. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 107. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 108. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 109. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 110. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 111. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 112. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 113. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 114. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 115. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 116. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 117. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 119. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 120. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 121. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 122. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 123. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 124. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 125. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 126. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 127. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 128. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 129. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 130. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 131. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 132. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 133. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 134. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 135. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 136. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 137. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 138. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 139. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 140. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 141. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 142. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 143. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 144. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 145. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 146. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 147. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 148. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 149. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 150. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 151. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 152. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 153. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 154. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 155. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 156. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 157. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 158. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 159. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 160. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 161. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 162. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 163. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
• TABLE 164. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 165. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 166. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 167. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 168. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 169. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
• TABLE 170. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)